Theriva Biologics Statistics
Total Valuation
TOVX has a market cap or net worth of $10.78 million. The enterprise value is $3.00 million.
| Market Cap | 10.78M |
| Enterprise Value | 3.00M |
Important Dates
The last earnings date was Tuesday, August 11, 2026, before market open.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TOVX has 45.89 million shares outstanding. The number of shares has increased by 834.13% in one year.
| Current Share Class | 45.89M |
| Shares Outstanding | 45.89M |
| Shares Change (YoY) | +834.13% |
| Shares Change (QoQ) | +11.74% |
| Owned by Insiders (%) | 1.63% |
| Owned by Institutions (%) | 5.12% |
| Float | 45.14M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 35.95 |
| Forward PS | n/a |
| PB Ratio | 0.88 |
| P/TBV Ratio | 0.88 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 10.00 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.13, with a Debt / Equity ratio of 0.29.
| Current Ratio | 1.13 |
| Quick Ratio | 1.09 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -101.87% and return on invested capital (ROIC) is -51.56%.
| Return on Equity (ROE) | -101.87% |
| Return on Assets (ROA) | -21.34% |
| Return on Invested Capital (ROIC) | -51.56% |
| Return on Capital Employed (ROCE) | -53.05% |
| Weighted Average Cost of Capital (WACC) | 7.82% |
| Revenue Per Employee | $18,750 |
| Profits Per Employee | -$820,500 |
| Employee Count | 16 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.71% in the last 52 weeks. The beta is 1.12, so TOVX's price volatility has been higher than the market average.
| Beta (5Y) | 1.12 |
| 52-Week Price Change | -46.71% |
| 50-Day Moving Average | 0.24 |
| 200-Day Moving Average | 0.24 |
| Relative Strength Index (RSI) | 52.28 |
| Average Volume (20 Days) | 518,761 |
Short Selling Information
The latest short interest is 2.12 million, so 4.61% of the outstanding shares have been sold short.
| Short Interest | 2.12M |
| Short Previous Month | 1.45M |
| Short % of Shares Out | 4.61% |
| Short % of Float | 4.69% |
| Short Ratio (days to cover) | 0.94 |
Income Statement
In the last 12 months, TOVX had revenue of $300,000 and -$13.13 million in losses. Loss per share was -$0.42.
| Revenue | 300,000 |
| Gross Profit | 300,000 |
| Operating Income | -12.07M |
| Pretax Income | -11.62M |
| Net Income | -13.13M |
| EBITDA | -11.96M |
| EBIT | -12.07M |
| Loss Per Share | -$0.42 |
Balance Sheet
The company has $11.34 million in cash and $3.55 million in debt, with a net cash position of $7.78 million or $0.17 per share.
| Cash & Cash Equivalents | 11.34M |
| Total Debt | 3.55M |
| Net Cash | 7.78M |
| Net Cash Per Share | $0.17 |
| Equity (Book Value) | 12.19M |
| Book Value Per Share | 0.27 |
| Working Capital | 1.56M |
Cash Flow
In the last 12 months, operating cash flow was -$12.74 million and capital expenditures -$22,000, giving a free cash flow of -$12.76 million.
| Operating Cash Flow | -12.74M |
| Capital Expenditures | -22,000 |
| Depreciation & Amortization | 103,000 |
| Net Borrowing | -14,000 |
| Free Cash Flow | -12.76M |
| FCF Per Share | -$0.28 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -4,022.00% |
| Pretax Margin | -3,872.67% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TOVX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -834.13% |
| Shareholder Yield | -834.13% |
| Earnings Yield | -121.73% |
| FCF Yield | -118.35% |
Analyst Forecast
The average price target for TOVX is $2.50, which is 963.83% higher than the current price. The consensus rating is "Buy".
| Price Target | $2.50 |
| Price Target Difference | 963.83% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 26, 2024. It was a reverse split with a ratio of 1:25.
| Last Split Date | Aug 26, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
TOVX has an Altman Z-Score of -15.49 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -15.49 |
| Piotroski F-Score | 2 |